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Abstract
Background: Recurrent hepatocellular carcinoma (HCC) in the extrahepatic bile duct is rare with most cases
diagnosed after manifesting sudden obstructive jaundice. Here, we report an extremely rare case of recurrent
HCC in the common bile duct due to hematogenous metastasis.
Case presentation: A 66-year-old man underwent an extended left hepatectomy for HCC in the medial segment
of the liver. Fifty months later, he presented with sudden obstructive jaundice. Endoscopic retrograde cholangiography
showed a space-occupying lesion in the common bile duct, which was suspected as cholangiocarcinoma. Therefore, he
underwent extrahepatic bile duct resection and choledochojejunostomy with lymph node dissection. Macroscopically,
a polypoid tumor and several nodular tumors were found in the common bile duct, which was obstructed by a tumor
thrombus. Histopathologically, the tumors were diagnosed as metastases from the HCC resected 50 months before.
Several distinct, nodular tumors were observed in the subepithelium of the common bile duct and had invaded
some blood vessels. These findings support the conclusion that the HCC metastasized hematogenously to the
extrahepatic bile duct.
Conclusions: Recurrent HCC in the extrahepatic bile duct due to hematogenous metastasis is rare, and it is
difficult to diagnose. Further similar cases should be accumulated for clarifying the pathological mechanism.
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Background
Curable hepatocellular carcinoma (HCC) is gradually in-
creasing because of improved follow-up and imaging
diagnosis protocols for chronic liver diseases. However, a
therapeutic strategy for metastasis and recurrence of HCC
remains a difficult topic. Recurrent HCC in the extrahe-
patic bile duct is somewhat rare, and almost all cases are
diagnosed after the manifestation of sudden obstructive
jaundice [1]. We report a case of recurrent HCC in the
common bile duct due to hematogenous metastasis with
tumor thrombus 50 months after primary hepatectomy.
Case presentation
A 66-year-old man with hepatitis C underwent an ex-
tended left hepatectomy for HCC in the medial segment
of the liver. Preoperative dynamic computed tomography
(CT) and intraoperative evaluation revealed no lymph
node metastasis (Fig. 1). Histopathologically, the 3.9-cm-
diameter tumor was confirmed to be moderately differ-
entiated HCC with trabecular structure. In addition to
microscopic venous invasion, tumor cells had extensively
invaded the portal vein, resulting in a tumor thrombus
in the left portal vein. There were several daughter nod-
ules of intrahepatic metastasis around the main tumor.
Although the resected margin was tumor negative,
tumor cells had invaded the serosa of the liver. There
was no obvious hepatic artery or bile duct invasion. His
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postoperative course was good, and his alpha fetoprotein
(AFP) and des-gamma-carboxy prothrombin (DCP)
levels were within normal limits. Follow-up CT exami-
nations were performed every 6 months. Fifty months
after the hepatectomy, he was referred to our hospital
with sudden obstructive jaundice. Laboratory studies
revealed hyperbilirubinemia (total bilirubin 10.5 mg/dl)
and a slight increase of DCP (85 mAU/ml); AFP levels
were normal. CT revealed dilation of the intrahepatic
biliary tree, but no definitive mass lesions were found in
the liver (Fig. 2a). In addition, there was an aneurysm in
the common hepatic artery. Magnetic resonance cholan-
giopancreatography revealed cholangiectasis from the
intrahepatic bile ducts to the middle segment of the
common bile duct (Fig. 2b). Wall thickening and a mass
showed low signal by T2-weighted imaging and high sig-
nal by diffusion-weighted imaging in the middle segment
of the common bile duct. Similar to CT, no definitive,
hepatic mass lesions were found. Fluorodeoxyglucose
positron emission tomography also showed solitary up-
take in the middle segment of the common bile duct.
Endoscopic retrograde cholangiopancreatography (ERCP)
Fig. 1 Computed tomography findings. There was a 30-mm
contrast-enhanced space-occupying lesion in hepatic segment 4
at the early phase (arrow). The lesion presented with washout at
the delay phase
Fig. 2 Preoperative imaging findings. a Computed tomography showed that cholangiectasis was observed in both anterior (arrow) and posterior
(triangle) segments of the right hepatic lobe, but no definitive mass lesions were found in the liver. b Magnetic resonance cholangiopancreatography
showed cholangiectasis from the intrahepatic bile ducts to the middle segment of the common bile duct. c Endoscopic retrograde
cholangiopancreatography showed that the common bile duct was obstructed by a tumorous lesion covering the upper and middle
segment of the common bile duct. d Dynamic liver magnetic resonance imaging showed that the tumor became ambiguous due to
the influence of the biliary drainage, and it had poor contrast effect in all contrast phases (the displayed image is early phase image).
No definitive mass lesions except for simple cysts were found in the liver
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showed that the common bile duct was obstructed by a
tumorous lesion covering the upper and mainly the mid-
dle segment of the common bile duct (Fig. 2c). Following
lesion biopsy, external biliary drainage was performed
using an endoscopic nasobiliary drainage (ENBD) tube.
After placing the ENBD tube, the patient underwent dy-
namic liver magnetic resonance imaging. In the dynamic
study, the tumor became ambiguous due to the influ-
ence of the biliary drainage, and it had poor contrast
effect in any contrast phase (Fig. 2d). Cytological exam-
ination of the biopsy specimen revealed atypical cells
forming papillary arrangement, which was suggestive of
cholangiocarcinoma rather than HCC. However, positiv-
ity was observed not only for AE1/AE3 but also for Hep
par 1. Although it was unclear whether the tumor was
cholangiocarcinoma or HCC from these pathological
features, the imaging studies suggested that the tumor
seemed to develop from the bile duct wall, which im-
plied cholangiocarcinoma rather than HCC. The patient
was to undergo surgical resection for diagnostic treat-
ment. Upon selection of the surgical procedure, we con-
sidered the pathological findings, patient’s hepatic spare
ability, local tumor extent based on ERCP, and common
hepatic artery aneurysm that posed a high risk for pan-
creaticoduodenectomy. Therefore, resection of extrahe-
patic bile duct and choledochojejunostomy with lymph
node dissection were performed on suspicion of solitary
cholangiocarcinoma. Complete resection (R0) was achieved
by pathologically determining negative surgical margin
during surgery.
Macroscopically, an approximately 10-mm-diameter
polypoid tumor continuous to the epithelium and a
tumor thrombus were found in the dilated common bile
duct, and several nodular tumors were observed sube-
pithelially (Fig. 3). The lesions and tumor thrombus were
diagnosed as moderately differentiated HCC (Fig. 4a, b).
Immunohistochemical staining revealed that they were
positive for Hep par 1 (Fig. 4c) and Glypican 3 (Fig. 4d)
but negative for both cytokeratin 7 and 20. Moreover,
these tumors showed microscopic venous (Fig. 4e) and
perineural invasion (Fig. 4f ) analyzed using D2-40 and
anti-CD31 antibodies. Microsections showed distinct,
numerous nodular tumors that were covered by the
epithelium and that did not invade the epithelium
(Fig. 4a, b). However, the polypoid lesion was not com-
pletely covered by the epithelium, protruding toward the
lumen of the bile duct with invasion. The tumor thrombus
was disconnected to both the tumor and the epithelium.
No metastasis was observed in dissected lymph nodes. On
the basis of these findings, the patient was diagnosed with
recurrent HCC in the extrahepatic bile duct due to
hematogenous metastasis. Six months after the surgery,
he developed multiple intrahepatic metastases and was
still alive at the time of drafting this report.
Discussion
HCC in the major bile duct, especially in the common bile
duct, can cause obstructive jaundice [1]. Such HCCs are
called icteric-type HCCs and tend to be complicated by
advanced clinical stage [2]. The most typical clinical find-
ing is obstructive jaundice confused with cholangiocarci-
noma [1]. Although most cases seem to originate from
tumor thrombi, the thrombi rarely stick to or invade the
bile duct wall [3, 4]. This case is unique because the recur-
rent HCC tumor due to hematogenous metastasis pene-
trated the bile duct wall and generated a tumor thrombus
50 months after the initial surgery. To the best of our
knowledge, except for our case, there has been only one
report of hematogenous HCC recurrence in the bile duct
[5]. However, their diagnosis was based only on circum-
stantial evidences, i.e., clinical and microscopic. Besides
Fig. 3 Macroscopic findings. A polypoid tumor (red triangle) of
approximately 10-mm diameter continuous with the epithelium
and a tumor thrombus (arrow) in the dilated common bile duct.
Several subepithelial nodules were observed (yellow triangles)
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HCC, there are three cases of colon [6, 7], two of kidney
[8, 9], and one of lung [10] cancers that reportedly showed
metastasis to the common bile duct. All the cases were
strongly considered that hematogenous metastasis from
the viewpoint of the anatomical positional relationship
between the common bile duct and each organ.
There are some rare reports of extrahepatic HCC
without primary hepatic parenchymal lesions [2, 11];
hence, the bile duct tumors in this case might be new
HCC lesions. However, the bile duct tumors in this case
were considered recurrence because of the morpho-
logical similarities and venous invasion. Furthermore,
most cases of primary extrahepatic HCC are continuous
and localized masses [12], whereas the tumors in this
case are extensively distinct and scattered.
HCC recurrence can be explained by the following
points: (i) invasive recurrence from microscopic bile duct
invasion; (ii) infiltrating recurrence of tumor thrombus
having been incompletely removed during primary hepa-
tectomy; (iii) invasion from the surrounding tissues of the
common bile duct; or (iv) recurrence of hematogenous
metastasis with microscopic venous invasion. In this case,
no microscopic bile duct invasions were observed in the
primary or recurrent HCCs. Furthermore, most recur-
rences originating from tumor thrombus have been re-
ported to develop within a year of surgery [4], unlike this
case in which recurrence occurred 50 months after
primary hepatectomy. Although a polypoid tumor was
observed to break through a part of the epithelium, nu-
merous lesions were extensively observed subepithelially.
Therefore, we consider that the recurrence originated
from hematogenous metastasis with microscopic venous
invasion, and the tumor thrombus was separated from the
polypoid tumor.
In this case, because (a) there were severe portal inva-
sion, (b) tumor thrombus was located in the left portal
vein, and (c) there were several daughter nodules of
microscopic intrahepatic metastasis, the patient had high
chance of recurrence. Despite such high-risk histo-
pathological findings, it is very interesting that he had a
disease-free interval of 50 months before recurrence.
The effectiveness of surgery for recurrence originating
from tumor thrombus has been previously reported
[13, 14]. Although thrombectomy is effective in the treat-
ment of bile duct tumor thrombus, positive outcomes of
bile duct resection with thrombus have been reported when
tumor thrombus has invaded the bile duct epithelium.
However, the recurrence in this case originated from
hematogenous metastasis and exhibited aggressive behavior
after the bile duct resection. Therefore, further cases and
studies are needed to reveal the effectiveness of surgery.
Conclusions
We report a patient who developed an extremely rare
recurrent HCC in the common bile duct due to
hematogenous metastasis. Recurrent HCC in the extra-
hepatic bile duct is rare and presents a poor prognostic
course. Further similar cases should be accumulated
for clarifying the pathological mechanism.
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Fig. 4 Microscopic findings. a Distinct, numerous nodular tumors covered by epithelium that did not expose the bile duct lumen (hematoxylin/eosin
(HE)). b These lesions were diagnosed as moderately differentiated HCC (HE). HCC immunostaining for c Hep par 1 and d Glypican 3. The nodular
tumors showed e microscopic venous and f perineural invasion (HE)
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